KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Land & Improvements (2016 - 2021)

Abbott Laboratories' Land & Improvements history spans 12 years, with the latest figure at $525.0 million for Q4 2021.

  • For Q4 2021, Land & Improvements fell 2.42% year-over-year to $525.0 million; the TTM value through Dec 2021 reached $525.0 million, down 2.42%, while the annual FY2021 figure was $525.0 million, 2.42% down from the prior year.
  • Land & Improvements for Q4 2021 was $525.0 million at Abbott Laboratories, down from $538.0 million in the prior quarter.
  • Across five years, Land & Improvements topped out at $538.0 million in Q4 2020 and bottomed at $501.0 million in Q4 2018.
  • The 5-year median for Land & Improvements is $525.0 million (2021), against an average of $521.8 million.
  • The largest annual shift saw Land & Improvements grew 28.92% in 2017 before it fell 4.75% in 2018.
  • A 5-year view of Land & Improvements shows it stood at $526.0 million in 2017, then dropped by 4.75% to $501.0 million in 2018, then increased by 3.59% to $519.0 million in 2019, then grew by 3.66% to $538.0 million in 2020, then dropped by 2.42% to $525.0 million in 2021.
  • Per Business Quant, the three most recent readings for ABT's Land & Improvements are $525.0 million (Q4 2021), $538.0 million (Q4 2020), and $519.0 million (Q4 2019).